In this respect, oral administration of FX (0.2, 0.4, and 0.6 %) was effective in reducing inflammation through reduction in IL-1β, TNF-α, iNOS, and COX-2 in a model of high-fat diet-induced obesity [296]. The gene discussed is TNF; the disease is obesity disorder.